Welcome to OMGEN

European Society of Gene and Cell Therapy

‘Overcoming barriers to commercialisation of ATMPs’ panel at the European Society of Gene and Cell Therapy (ESGCT) 29th Congress in Edinburgh

At OMGEN, we specialiSe in working with life-sciences clients to develop winning strategies for RARE disease and gene therapy products, providing insightful consulting services, and navigating transformative change.

Our comprehensive approach encompasses: